Delivery Order SPE2D020D0009-SPE2D022F0322
- Not listed
- The Defense Logistics Agency (DLA) Troop Support Medical division awarded a firm fixed-price delivery order contract valued at $2,451.11 to Fresenius Kabi, LLC, a foreign-owned for-profit pharmaceutical company. The order is for ketorolac tromethamine injection (Toradol) to be delivered by February 16, 2024. This award is likely against an existing government-wide acquisition vehicle or blanket purchase agreement to replenish stocks of this injectable pain medication for military medical...
- Fresenius Kabi, LLC, a pharmaceutical company headquartered in Lake Zurich, Illinois, received a delivery order from the Medical Supply Chain on September 29, 2025, for Ketorolac 30 mg/mL vials with a ceiling value of $1,065.70. This is a firm fixed-price contract with an ultimate completion date of September 30, 2025, and carries no set-aside designation. As a child contract, this delivery order is issued under Fresenius Kabi's existing Federal Supply Schedule contract with the Veterans...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is for the delivery of DOXYCYCLINE HYDROCHLORIDE INJECTION (10), a critical care medication, to military medical facilities worldwide. The contract has a ceiling value of $79,808.27 and is a firm fixed-price, non-set-aside delivery order with a completion date of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company. The contract is for the supply of doxycycline hydrochloride injection, a critical care medication, to military medical facilities worldwide. The ceiling value of this firm-fixed price contract is $25,923.80, and the ultimate completion date is September 27, 2024. This delivery order is not set aside. Fresenius Kabi is...
- This federal contract award is for the delivery of Doxycycline Hydrochloride Injection (10) to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The prime contractor is Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is a delivery order with a firm fixed price of $22,035.23 and a completion date of September 27, 2024. There is no set-aside designation associated with this contract. Fresenius Kabi, LLC...
- This federal contract award was made by the Defense Logistics Agency Troop Support Medical to Fresenius Kabi USA, LLC, a foreign-owned, for-profit pharmaceutical company, to provide a variety of intravenous solutions, generic injectable medicines, infusion therapies, and medical devices. The $308,121.52 firm fixed price contract was awarded on July 27, 2018 and has a completion date of August 29, 2019. The award was not set aside and was made through the Pharmaceuticals and Drugs Federal...
- Fresenius Kabi, LLC, a pharmaceutical supplier headquartered in Lake Zurich, Illinois, was awarded a delivery order valued at $1,278.84 by the Medical Supply Chain, a defense-focused federal agency, on September 18, 2025. The contract calls for the delivery of Ketorolac 30 mg/ml vials and is classified as a firm fixed-price delivery order with an ultimate completion date of September 19, 2025. The place of performance is Lake Zurich, Illinois. No set-aside designation was applied to this...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at sixty-two thousand three hundred thirty-five US dollars to Fresenius Kabi, LLC. The order is for furosemide injection solution to be delivered from Lake Zurich, Illinois between July nineteenth and twenty-fourth, two thousand twenty-three. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency supports Department of Defense health care programs by...
- Fresenius Kabi, LLC was awarded a firm fixed price delivery order valued at sixty-two dollars by the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical) on August 28, 2023. The contract is for the delivery of Furosemide 10 mg/ml injection solution to Lake Zurich, Illinois with a period of performance through August 31, 2023. No set-aside designation was used for this award, which is associated with the Defense Logistics Agency's medical supply chain to support the health...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Furosemide 100 mg/10 ml vials. The contract has a ceiling value of $2,025.57 and a completion date of August 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which...
- SPE2D020D0009Indefinite Delivery Contract
- SPE2D020D0009-SPE2D022F0322Delivery Order
This is a delivery order contract awarded to Fresenius Kabi, LLC, a foreign-owned for-profit pharmaceutical company, by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract is for the delivery of various generic injectable pharmaceutical products, including medications like ketorolac, furosemide, lidocaine, diphenhydramine, and atropine, to support the medical supply needs of military facilities worldwide. The contract has a ceiling value of $1,257,405.54 and a period of performance through July 31, 2023. The order is a firm fixed-price delivery contract against an unspecified government-wide acquisition vehicle or blanket purchase agreement. No set-asides were used for this commodity pharmaceutical procurement. Fresenius Kabi also holds a separate 5-year, $2.24 million indefinite delivery contract with the Department of Veterans Affairs National Acquisition Center to provide the cancer treatment drug bortezomib, with orders to be placed through March 2028.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3m | 7/25/22 |